Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm-Reference-Cited by-同舟云学术

Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm

Published:2021-01 Issue:1 Volume:44 Page:84-98
ISSN:0253-6269
Container-title:Archives of Pharmacal Research
language:en
Short-container-title:Arch. Pharm. Res.

Author:

Lee Chang Hoon^ORCID

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12272-020-01299-y.pdf

Reference135 articles.

1. Abouelasrar Salama S, Lavie M, De Buck M, Van Damme J, Struyf S (2019) Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection. Cytokine Growth Factor Rev 50:29–42. https://doi.org/10.1016/j.cytogfr.2019.10.006

2. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201:713–722. https://doi.org/10.1084/jem.20042031

3. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912–3917. https://doi.org/10.1084/jem.20042031

4. Asha K, Balfe N, Sharma-Walia N (2020) Concurrent Control of the Kaposi’s Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4. J Virol 94:e02177–e02119. https://doi.org/10.1128/JVI.02177-19

5. Baillie JK, Digard P (2013) Influenza–time to target the host? N Engl J Med 369:191–193. https://doi.org/10.1056/NEJMcibr1304414

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities;Antioxidants;2024-03-22

2. Unsaturated fatty acids, omega-3 index and hospitalization in MISC;Prostaglandins, Leukotrienes and Essential Fatty Acids;2024-03

3. Resolution pharmacology and the treatment of infectious diseases;British Journal of Pharmacology;2024-02-14

4. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein;Prostaglandins & Other Lipid Mediators;2023-12

5. Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation;Prostaglandins & Other Lipid Mediators;2023-10